$CRCL-20.11%$NBIS+0.67%called by @SteveUrkelDude$AXTI+6.21%called by @PolarizingLit$SNDK0.00%$ONTO+4.61%$RKLB-2.84%called by @SteveUrkelDude$GEV+3.03%$NKTR-1.86%called by @LTbioinvestor$MP+0.02%$ALAB-1.70%$AAOI+18.94%called by @MarcJacksonLA$AMD+1.33%$INTC+0.11%$CRML-3.27%$AEHR+5.49%called by @RodmanM1$MU-2.18%called by @SteveUrkelDude$OPTX+4.09%$CRCL-20.11%$NBIS+0.67%called by @SteveUrkelDude$AXTI+6.21%called by @PolarizingLit$SNDK0.00%$ONTO+4.61%$RKLB-2.84%called by @SteveUrkelDude$GEV+3.03%$NKTR-1.86%called by @LTbioinvestor$MP+0.02%$ALAB-1.70%$AAOI+18.94%called by @MarcJacksonLA$AMD+1.33%$INTC+0.11%$CRML-3.27%$AEHR+5.49%called by @RodmanM1$MU-2.18%called by @SteveUrkelDude$OPTX+4.09%
Morning BriefingTuesday, Jun 9, 2026
Buy Zone5 picks: ONDS, SMCI, NVTS…
Exit Alerts0 warnings issued
Fear & GreedGREED67
SPY ETF+0.78% (Pre-Market)
Livesync 0s ago
Callers
Single-call
Leaderboard #78

@BioValues

Was 17 days early on $SNSE. A single call this early is luck or genius — we track until we know which.

View @BioValues on X
Score
0.305
0.5+ = strong
Best lead
17d
on $SNSE
Winners
1
single call
Pre-run tweets
14
substantive only

Calls breakdown

$SNSECalled 17 days before runClosed
first mention: Apr 15, 2024
“Started another contrarian long position - $SNSE . Topline monotherapy and combo data for anti-VISTA mAb SNS-101 coming at ASCO. They believe they have overcome the previous hurdles of dosing up to therapeutic levels for VISTA. Market cap $25M vs. cash ~$60M. Like the R/R here”
View tweet
6 other callers also flagged $SNSE pre-run:
PR
@ProfitGrand
LT
@LTbioinvestor
MA
@MarcJacksonLA
OZ
@OzmosiHealth
BP
@BPharmCatalyst
MO
@monaco_biotech